PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsatrial fibrillation
MeSH D001281 - atrial fibrillation
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D001145:Cardiac arrhythmias
145 Companies
29 Drugs
$
Success rate
D001281: 
Atrial fibrillation
131 Companies
26 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
A.H. Robins CompanyQuinidine Quinidine  1982-01-01   
Abbott BiotherapeuticsWarfarin Panwarfin  1982-01-01   
AbbVieVerapamil, Trandolapril Tarka  1996-10-22   
Able LaboratoriesAtenolol Atenolol  2004-07-30   
Accord HealthcareDiltiazem Diltiazem  2020-04-28   
Dofetilide Dofetilide  2020-06-19   
Metoprolol Metoprolol  2022-10-18   
Rivaroxaban Rivaroxaban Accord  2020-11-16   
Alembic PharmaceuticalsMetoprolol Metoprolol  2013-05-28   
Hydrochlorothiazide, Metoprolol Metoprolol Hydrochlorothiazide  2013-11-06   
Alkem LaboratoriesMetoprolol Metoprolol  2020-11-25   
AllerganDiltiazem Dilacor  1992-05-29   
Atenolol Atenolol  1991-12-27   
Atenolol, Chlorthalidone Atenolol Chlorthalidone  1992-07-02   
Diltiazem Cartia  1998-07-09   
Dextromethorphan, Quinidine Dextromethorphan Quinidine  2017-10-10   
Diltiazem Diltiazem  1997-10-10   
Disopyramide Disopyramide  1986-02-02   
Metoprolol Metoprolol  1993-12-21   
Procainamide Procainamide  1982-01-01   
Propafenone Propafenone  2000-10-24   
Quinidine Quinatime  1982-01-01   
Quinidine Quinidine  1982-01-01   
Sotalol Sotalol  2000-07-13   
Diltiazem Taztia  2003-04-10   
Verapamil Verapamil  1986-09-24   
Warfarin Warfarin  1982-08-17   
AltaThera PharmaceuticalsSotalol Sotalol 2038-08-14 2009-07-02   
AlvogenFlecainide Tambocor  1985-10-31   
1
2
3
4
5
6
...
14
>
Clinical Trials
Historical Success Rate
Phase 1
90%
18/20
Phase 2
57%
40/70
Phase 3
71%
71/100
Approved: 25Overall Success rate: 37%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Abbott Biotherapeutics
Warfarin,
Salicylic acid,
Dabigatran,
Antithrombin iii,
Vitamin k,
Enoblituzumab,
Ademetionine,
Serine,
Sodium chloride,
Sodium lactate,
Aldosterone,
Microcrystalline cellulose,
Retinol,
Corticoids,
Avlocardyl,
Ccb,
Solumedrol,
Betaloc,
Evidence,
Kcl,
Merlin
AbbVie
Azzalure
Allergan
Dextromethorphan
1
2
3
4
5
6
...
9
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use